FMS News and Press, Fresenius Medical Care AG From 09/11/20

Quick Take Outset Medical ( OM ) has filed to raise $175 million from the sale of its common stock in an IPO, according to an amended registration statement . The company has developed an improved kidney dialysis device for institutional and home use. OM is growing quickly from a low ba...

As a whole set of factors should be negatively impacting markets, such as the ongoing pandemic, an uncertain path to economic recovery and the even more uncertain November U.S. Presidential Elections, markets are shaking off these concerns and racing to new highs almost every single day in Aug...

Investment Thesis Baxter International's (BAX) global presence signals fundamental strength, albeit with a bumpy Q2 exit, missing the Street's estimates on revenue by -4%, net income by -21% and EPS by $0.07. BAX has comparative advantages relative to peers within the medical devices and ins...

It can be difficult to find bargains in the middle of a historic rally, but they do exist. Here are four stocks with great long-term potential trading at attractive valuations: The Kroger Company (KR), Fresenius Medical Care (FMS), Humana (HUM), and AutoNation (AN). Investing during a stoc...

Quick Take Outset Medical ( OM ) has filed to raise $100 million in an IPO of its common stock, according to an S-1 registration statement . The firm has developed a patented hemodialysis machine for patients with reduced kidney function. OM looks well positioned to provide a differenti...

German dialysis firm Fresenius Medical Care ( FMS ) is the biggest dialysis provider in the U.S., and at present is an excellent choice for value investors and income investors alike. Fresenius Medical Care can trace its roots back to 1462 , when the Hirsch Pharmacy of Frankfurt was founded...

Foreword Yield-based (dog catcher) analysis makes any collection of stocks is more easily understood. These Kiplinger "Top Dividend Stocks From Around The World" (a.k.a. the most reliable dividends on earth) are perfect for the dogcatcher process. Here is the August 10 data for 91 div...

Quick Take PainReform ( PRFX ) intends to raise $23 million from the sale of its common stock in an IPO, according to an amended registration statement . The company is developing a reformulated pain relief medication for post-operative pain reduction. PRFX management has performed well...

Image source: The Motley Fool. Fresenius Medical Care AG & Co. KGaA   (NYSE: FMS) Q2 2020 Earnings Call Jul 30, 2020 , 2:30 p.m. ET Operator Continue reading

Fresenius Medical Care AG & Co. KGaA (FMS) Q2 2020 Earnings Conference Call July 30, 2020, 09:30 ET Company Participants Dominik Heger - EVP & Head, IR, Strategic Development & Communications Robert Powell - Chairman & CEO Helen Giza - CFO Conference Call Parti...